pinocembrin has been researched along with Alzheimer Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, XY; Du, GH; Huang, C; Li, JZ; Li, L; Li, YJ; Liu, R; Song, JK; Wu, CX; Xie, T; Zhang, L; Zhang, TT; Zhang, X; Zhou, D | 1 |
| Du, GH; Liu, R; Tian, S; Wu, CX; Yang, F; Zhang, L; Zhang, TT; Zhou, D | 1 |
2 other study(ies) available for pinocembrin and Alzheimer Disease
| Article | Year |
|---|---|
Pinocembrin improves cognition and protects the neurovascular unit in Alzheimer related deficits.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Brain-Derived Neurotrophic Factor; Cognition; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Female; Flavanones; Male; MAP Kinase Signaling System; Mice; Neuroprotective Agents; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Signal Transduction | 2014 |
Pinocembrin protects against β-amyloid-induced toxicity in neurons through inhibiting receptor for advanced glycation end products (RAGE)-independent signaling pathways and regulating mitochondrion-mediated apoptosis.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Cerebral Cortex; Cognition; Disease Models, Animal; Flavanones; Gene Expression Profiling; Male; Mice; Mitochondria; Nerve Degeneration; Neurons; Neuroprotective Agents; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Signal Transduction | 2012 |